Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina

This study aimed to evaluate well-documented diagnostic antigens, named B13, 1F8 and JL7 recombinant proteins, as potential markers of seroconversion in treated chagasic patients. Prospective study, involving 203 patients treated with benznidazole, was conducted from endemic areas of northern Argent...

Full description

Saved in:

Bibliographic Details
Published in:	Memórias do Instituto Oswaldo Cruz Vol. 111; no. 6; pp. 365 - 371
Main Authors:	Niborski, Leticia L, Grippo, Vanina, Lafón, Sonia O, Levitus, Gabriela, García-Bournissen, Facundo, Ramirez, Juan C, Burgos, Juan M, Bisio, Margarita, Juiz, Natalia A, Ayala, Vilma, Coppede, María, Herrera, Verónica, López, Crescencia, Contreras, Ana, Gómez, Karina A, Elean, Juan C, Mujica, Hugo D, Schijman, Alejandro G, Levin, Mariano J, Longhi, Silvia A
Format:	Journal Article
Language:	English
Published:	Brazil Fundação Oswaldo Cruz, Fiocruz 01-06-2016 Instituto Oswaldo Cruz, Ministério da Saúde Fundação Oswaldo Cruz (FIOCRUZ)
Subjects:	Adult adverse effects Antibodies, Protozoan - blood Antigens, Protozoan - immunology Argentina benznidazole treatment Chagas Disease - blood Chagas Disease - drug therapy chronic Chagas disease Chronic Disease Cohort Studies Enzyme-Linked Immunosorbent Assay Female Follow-Up Studies Humans Male Middle Aged Nitroimidazoles - therapeutic use PARASITOLOGY Prospective Studies serological follow-up Time Factors TROPICAL MEDICINE Trypanocidal Agents - therapeutic use Trypanosoma cruzi Young Adult benznidazole treatment adverse effects serological follow-up chronic Chagas disease Trypanosoma cruzi
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!